ES2147780T3 - Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos. - Google Patents

Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.

Info

Publication number
ES2147780T3
ES2147780T3 ES94900557T ES94900557T ES2147780T3 ES 2147780 T3 ES2147780 T3 ES 2147780T3 ES 94900557 T ES94900557 T ES 94900557T ES 94900557 T ES94900557 T ES 94900557T ES 2147780 T3 ES2147780 T3 ES 2147780T3
Authority
ES
Spain
Prior art keywords
oak bark
bark extract
ions
procedure
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94900557T
Other languages
English (en)
Inventor
David N S Hon
R Thomas Stanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greystone Medical Group Inc
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Application granted granted Critical
Publication of ES2147780T3 publication Critical patent/ES2147780T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Laminated Bodies (AREA)
  • Road Paving Structures (AREA)
  • Cosmetics (AREA)

Abstract

LAS CONCENTRACIONES MAS ALTAS DE EXTRACTO DE CENIZA DE CORTEZA DE ROBLE, POR EJEMPLO, MAS GRANDES QUE EL 20% DE PESO, SON UTILES PARA EL TRATAMIENTO DE CANCERES DE PIEL. LAS CONCENTRACIONES DE EXTRACTO DE CORTEZA DE ROBLE POSEEN PROPIEDADES TERAPEUTICAS ADICIONALES NO POR ELLO RECONOCIDAS. POR EJEMPLO, LOS PREPARADOS QUE CONTIENEN EL 40-80% DE EXTRACTOS DE CORTEZA DE ROBLE SON UTILES EN EL TRATAMIENTO DE ULCERAS DE PIEL CANCEROSAS AGUDAS. EN ADICION, LAS MEZCLAS SINTETICAS QUE CONTIENEN IONES DE POTASIO, IONES DE ZINC, IONES DE CALCIO PROVEEN MUCHAS DE LAS MISMAS PROPIEDADES VENTAJOSAS DEL EXTRACTO DE CORTEZA DE ROBLE. LA INCLUSION DE IONES DE RUBIDIO Y AZUFRE ES TAMBIEN VENTAJOSA PARA ALGUNAS APLICACIONES.
ES94900557T 1992-11-06 1993-11-04 Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos. Expired - Lifetime ES2147780T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06

Publications (1)

Publication Number Publication Date
ES2147780T3 true ES2147780T3 (es) 2000-10-01

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94900557T Expired - Lifetime ES2147780T3 (es) 1992-11-06 1993-11-04 Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.

Country Status (21)

Country Link
US (1) US6149947A (es)
EP (1) EP0668769B1 (es)
JP (1) JP3640215B2 (es)
AT (1) ATE191850T1 (es)
AU (1) AU700019B2 (es)
BR (1) BR9307401A (es)
CA (1) CA2148795C (es)
CY (1) CY2231B1 (es)
CZ (1) CZ117395A3 (es)
DE (1) DE69328438T2 (es)
DK (1) DK0668769T3 (es)
ES (1) ES2147780T3 (es)
HU (1) HUT73791A (es)
MX (1) MX9306960A (es)
NO (1) NO951740L (es)
NZ (1) NZ258019A (es)
OA (1) OA10153A (es)
PL (1) PL308770A1 (es)
PT (1) PT668769E (es)
WO (1) WO1994011010A2 (es)
ZA (1) ZA938274B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
AU2002359529B2 (en) * 2001-11-29 2008-02-21 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
JP2005527613A (ja) * 2002-05-24 2005-09-15 グレイストーン メディカル グループ、インコーポレイテッド 抗癌製剤
JP2006511585A (ja) * 2002-12-23 2006-04-06 グレイストーン メディカル グループ、インコーポレイテッド 慢性創傷管理における活性酸素種の減少
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
JP2008503592A (ja) * 2004-06-22 2008-02-07 グレイストーン メディカル グループ、インコーポレイテッド 徐放性組成物を用いた創傷の治療方法
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
WO2007089267A1 (en) 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
CA2700990C (en) 2007-03-15 2014-08-12 Om Kataria Uterine stimulant sticks
ES2652114T3 (es) 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
WO2011103158A1 (en) * 2010-02-16 2011-08-25 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
JP2014520657A (ja) * 2011-07-20 2014-08-25 スリーエム イノベイティブ プロパティズ カンパニー イオン担持組成物を含んだ包帯
EP2736486B1 (en) * 2011-07-28 2019-03-06 3M Innovative Properties Company Wound-healing compositions and method of use
CN103732192B (zh) 2011-08-17 2016-03-16 3M创新有限公司 单体接枝纤维及其用途
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
US10500235B2 (en) 2015-01-29 2019-12-10 San Melix Laboratories, Inc. Wound healing compositions comprising buckwheat honey and methylglyoxal and methods of use
BR112021017547A2 (pt) * 2019-03-04 2021-11-09 Celloryx AG Bactéria recombinante, ácido nucleico recombinante, dispositivo médico, composição farmacêutica, kit para uso em medicina e uso de um meio de reconstituição
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US256847A (en) * 1882-04-25 Salve
US37901A (en) * 1863-03-17 Improved liniment
US55911A (en) * 1866-06-26 Improved medical compound
US202246A (en) * 1878-04-09 Improvement in medical compounds
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
ATE69954T1 (de) * 1985-10-08 1991-12-15 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
AU5550094A (en) 1994-06-08
DE69328438D1 (de) 2000-05-25
CZ117395A3 (en) 1995-11-15
CA2148795A1 (en) 1994-05-26
DK0668769T3 (da) 2000-10-02
NO951740L (no) 1995-06-19
EP0668769B1 (en) 2000-04-19
US6149947A (en) 2000-11-21
PT668769E (pt) 2000-10-31
NO951740D0 (no) 1995-05-04
EP0668769A1 (en) 1995-08-30
DE69328438T2 (de) 2001-01-04
PL308770A1 (en) 1995-08-21
HU9501323D0 (en) 1996-05-28
WO1994011010A2 (en) 1994-05-26
CY2231B1 (en) 2003-04-18
HUT73791A (en) 1996-09-30
OA10153A (en) 1996-12-18
WO1994011010A3 (en) 1994-09-15
ATE191850T1 (de) 2000-05-15
BR9307401A (pt) 1999-08-24
JP3640215B2 (ja) 2005-04-20
ZA938274B (en) 1994-06-09
AU700019B2 (en) 1998-12-17
NZ258019A (en) 1998-12-23
MX9306960A (es) 1995-01-31
CA2148795C (en) 2004-08-10
JPH08503462A (ja) 1996-04-16

Similar Documents

Publication Publication Date Title
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
FI943805A (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
ES2033434T3 (es) Composicion cosmetica.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
NO820429L (no) Tetrahydronaftalin- og indanforbindelser
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE59908268D1 (de) Khellin-zubereitung und deren verwendung zur topischen therapie
DE59303033D1 (de) Hautbräunungsmittel
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
ATE128354T1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
GB8428552D0 (en) Organic compounds
ES2106858T3 (es) Nuevos derivados de la citarabina, su procedimiento de preparacion y su uso contra enfermedades cancerosas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 668769

Country of ref document: ES